PL3297625T3 - Związek do profilaktyki lub leczenia nefropatii cukrzycowej lub cukrzycowej choroby nerek - Google Patents

Związek do profilaktyki lub leczenia nefropatii cukrzycowej lub cukrzycowej choroby nerek

Info

Publication number
PL3297625T3
PL3297625T3 PL16723346.9T PL16723346T PL3297625T3 PL 3297625 T3 PL3297625 T3 PL 3297625T3 PL 16723346 T PL16723346 T PL 16723346T PL 3297625 T3 PL3297625 T3 PL 3297625T3
Authority
PL
Poland
Prior art keywords
diabetic
prevention
compound
treatment
kidney disease
Prior art date
Application number
PL16723346.9T
Other languages
English (en)
Inventor
Adrianus Cornelis Van Der Graaf
Robert Henk Henning
Leo Edwin DEELMAN
Gerrit Jan Willem Euverink
Original Assignee
Sulfateq B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56014996&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3297625(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sulfateq B.V. filed Critical Sulfateq B.V.
Publication of PL3297625T3 publication Critical patent/PL3297625T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL16723346.9T 2015-05-22 2016-05-12 Związek do profilaktyki lub leczenia nefropatii cukrzycowej lub cukrzycowej choroby nerek PL3297625T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2014843 2015-05-22
PCT/EP2016/060731 WO2016188766A1 (en) 2015-05-22 2016-05-12 Compound for the prophylaxis or treatment of organ damage

Publications (1)

Publication Number Publication Date
PL3297625T3 true PL3297625T3 (pl) 2022-11-14

Family

ID=56014996

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16723346.9T PL3297625T3 (pl) 2015-05-22 2016-05-12 Związek do profilaktyki lub leczenia nefropatii cukrzycowej lub cukrzycowej choroby nerek

Country Status (15)

Country Link
US (2) US10676452B2 (pl)
EP (1) EP3297625B1 (pl)
JP (2) JP6967456B2 (pl)
CN (1) CN107660148B (pl)
AU (1) AU2016268975B2 (pl)
BR (1) BR112017024854B1 (pl)
CA (1) CA2986300C (pl)
CL (1) CL2017002960A1 (pl)
DK (1) DK3297625T3 (pl)
ES (1) ES2927699T3 (pl)
HU (1) HUE060167T2 (pl)
MX (1) MX388654B (pl)
PL (1) PL3297625T3 (pl)
PT (1) PT3297625T (pl)
WO (1) WO2016188766A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2010010C2 (en) * 2012-12-19 2014-06-23 Sulfateq B V Compounds for protection of cells.
CA2986300C (en) * 2015-05-22 2024-02-20 Sulfateq B.V. Compound for the prophylaxis or treatment of organ damage
WO2019038360A1 (en) 2017-08-25 2019-02-28 Sulfateq B.V. 6-CHROMANOL DERIVATIVES FOR USE AS A MEDICINAL PRODUCT
EP3672593B1 (en) 2017-08-25 2024-12-18 Sulfateq B.V. Medicaments for the treatment of vasoconstriction related diseases or disorders
CA3079483A1 (en) 2017-11-22 2019-05-31 Khondrion Ip B.V. Compounds as mpges-1 inhibitors
NL2025730B1 (en) * 2020-06-02 2022-01-20 Sulfateq Bv Compounds for treatment of sepsis
NL2026511B1 (en) * 2020-09-21 2022-05-24 Sulfateq Bv Compounds for treatment of heart failure

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681890A (en) 1984-10-30 1987-07-21 Kuraray Co., Ltd. 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
CA1286299C (en) 1985-05-13 1991-07-16 Johji Yamahara 3,4-dihydrobenzopyran derivatives and medicinal uses thereof
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
US5266709A (en) 1989-03-13 1993-11-30 Ono Pharmaceutical Co., Ltd. Benzopyran derivatives
US5506245A (en) * 1992-10-12 1996-04-09 Adir Et Compagnie Thiazolidinedione compounds
US5457109A (en) 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
FR2756284B1 (fr) 1996-11-26 2000-04-28 Adir Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6335445B1 (en) * 1997-03-24 2002-01-01 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
DE69716592T2 (de) 1997-05-02 2003-06-26 Dr. Reddy's Laboratories Ltd., Hyderabad Neue heterozyklische verbindungen mit antidiabetischen, hypolipiddaemischen und blutdrucksenkenden eigenschaften, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten
AR019190A1 (es) * 1998-07-08 2001-12-26 Sod Conseils Rech Applic Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
WO2004076437A1 (en) 2003-02-26 2004-09-10 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Benzopyran compounds, process for preparing the same and their use
AU2004260758B2 (en) * 2003-08-01 2007-06-07 Nippon Soda Co., Ltd. Phenylazole compounds, production process, and antioxidants
WO2005033092A1 (en) * 2003-09-19 2005-04-14 Galileo Pharmaceuticals, Inc. Chroman derivatives
KR102137450B1 (ko) * 2012-07-12 2020-07-27 콘드리온 아이피 비.브이. 미토콘드리아 질환을 치료하기 위한 크로마닐 유도체
NL2010010C2 (en) 2012-12-19 2014-06-23 Sulfateq B V Compounds for protection of cells.
CA2986300C (en) * 2015-05-22 2024-02-20 Sulfateq B.V. Compound for the prophylaxis or treatment of organ damage

Also Published As

Publication number Publication date
EP3297625B1 (en) 2022-07-06
CL2017002960A1 (es) 2018-03-16
MX2017014912A (es) 2018-06-13
WO2016188766A1 (en) 2016-12-01
CA2986300C (en) 2024-02-20
ES2927699T3 (es) 2022-11-10
DK3297625T3 (da) 2022-10-17
CA2986300A1 (en) 2016-12-01
EP3297625A1 (en) 2018-03-28
US20210024485A1 (en) 2021-01-28
HUE060167T2 (hu) 2023-02-28
JP2021120381A (ja) 2021-08-19
US10676452B2 (en) 2020-06-09
MX388654B (es) 2025-03-20
AU2016268975B2 (en) 2021-08-12
BR112017024854B1 (pt) 2023-12-26
US20180170892A1 (en) 2018-06-21
JP6967456B2 (ja) 2021-11-17
BR112017024854A2 (pt) 2018-08-14
CN107660148B (zh) 2021-03-09
AU2016268975A1 (en) 2017-11-30
CN107660148A (zh) 2018-02-02
PT3297625T (pt) 2022-09-27
JP2018520106A (ja) 2018-07-26

Similar Documents

Publication Publication Date Title
IL256209A (en) Novel cannabinoid combination therapies for multiple myeloma (mm)
IL247111A0 (en) Preventive or therapeutic agent for kidney disease
IL253945B (en) kdm1a inhibitors to treat the disease
LT3334422T (lt) Kanabidiolio rūgšties panaudojimas epilepsijos gydymui
DK3474804T4 (da) Medicinsk forbinding
DK3212233T3 (da) Kombinationsterapi til behandling af sygdom
HUE059694T2 (hu) Készítmény rák kezelésére
IL258684A (en) Combination therapy for treating malignancies
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
BR112017018413A2 (pt) tratamento de pancreatite
DK3148529T3 (da) Forbindelser til behandling af hjernecancer
HUE055263T2 (hu) 11-Szubsztituált 24-hidroxiszterolok NMDA-hoz kapcsolódó állapotok kezelésére
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
EP3302325A4 (en) CRYOABLATION CATHETER WITH AN ELLIPTICALLY SHAPED TREATMENT PROFILE
LT3210973T (lt) Heteroarilo junginiai, skirti akių ligų gydymui
HUE060517T2 (hu) Immunhiányos betegség kezelésére szolgáló eljárások
IL257355B (en) Selection of patients for combination therapy
HUE060167T2 (hu) Diabéteszes nefropátia vagy diabéteszes vesebetegségek megelõzésére vagy kezelésére szolgáló vegyület
EP3307268A4 (en) SUBSTITUTED PHENYLOXAZOLIDINONE FOR ANTIMICROBIAL THERAPY
SI3522880T1 (sl) Postopki zdravljenja akutne poškodbe ledvic
LT3534885T (lt) Farneziltransferazės inhibitoriai, skirti naudoti vėžio gydymui
IL256111B1 (en) Pac–1 combination therapy
DK3308781T3 (da) Antihypertensivt middel
IL259297A (en) Heterocyclic compounds for the treatment of disease
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner